Researchers have found a way to consistently grow Helper T cells from stem cells in the lab, a breakthrough that could make advanced cancer therapies faster, cheaper, and more accessible. Helper T cells are important because they coordinate and strengthen the immune response, but until now they were very difficult to produce reliably.
The team discovered that a biological signal called Notch controls whether stem cells become Helper or Killer T cells. By carefully adjusting this signal at the right time, scientists can now guide stem cells to become either type of T cell on demand. This means both Helper and Killer T cells can be produced together, making immunotherapies more effective at attacking tumors and preventing relapse.
This breakthrough could lead to “off-the-shelf” T cell therapies, available immediately for patients, rather than customized treatments that take weeks to prepare. Beyond cancer, these lab-grown cells could help treat infectious diseases, autoimmune disorders, and even support organ transplants by creating specialized immune cells to calm the immune system.